Search

everythinglearnresearchcommunity

for

Search:↓

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Melatonin affects certain genes and pathways involved in cashmere goat hair growth.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

COVID-19 infection may trigger alopecia areata in some patients.

Manipulating cell cleanup processes could help treat hair loss.

New understanding and treatments for hair loss are improving, but more research is needed.

New biofabrication technologies could lead to treatments for hair loss.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

The human scalp hair bulb contains different types of melanocytes with varying abilities to produce melanin.

Targeting Vδ1+T-cells may help treat alopecia areata.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Different fields of expertise must work together to better understand hair growth and create effective hair loss treatments.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Ginseng, especially its component ginsenosides, can promote hair growth, reduce hair loss, and potentially treat conditions like alopecia by affecting cell pathways and cytokines.

Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Researchers identified genes and proteins that may influence wool thickness in sheep.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Dandruff might be caused by changes in how hair follicles naturally release oils and an immune response to this imbalance.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Different genes are active in dogs' hair growth and skin, similar to humans, which helps understand dog skin and hair diseases and can relate to human conditions.